Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer.
Saved in:
| Title: | Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer. |
|---|---|
| Authors: | Liu F; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Monterosso ME; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Boucher D; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Shakti S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Li KC; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kim C; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Prior A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Sydes A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Soderholm AT; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Fletcher N; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Akhter D; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Thurecht K; Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Tieu W; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kuan K; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Horsfall A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kumar S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Koehbach J; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Hammond E; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Karmann A; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Rose S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Li G; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au., Puttick S; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and., Kryza T; AdvanCell Pty Ltd., Sydney, New South Wales, Australia; and thomas.kryza@advancell.com.au gary.li@advancell.com.au. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Nov 03; Vol. 66 (11), pp. 1703-1713. Date of Electronic Publication: 2025 Nov 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.269707 |
